Cadherin-17 and SATB2 are sensitive and specific immunomarkers for medullary carcinoma of the large intestine

Archives of Pathology and Laboratory Medicine

Volumn 138, Issue 8, 2014, Pages 1015-1026

  Lin, Fan ^a   Shi, Jianhui ^a   Zhu, Shaobo ^a   Chen, Zongming ^a   Li, Aihua ^b   Chen, Taiying ^b   Wang, Hanlin L ^c   Liu, Haiyan ^a  

^a GEISINGER MEDICAL CENTER   (United States)

^b Division of In Vitro Diagnostics Epitomics Inc Abcam Company ^*  (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; BIOLOGICAL MARKER; CADHERIN; CDH17 PROTEIN, HUMAN; DNA BINDING PROTEIN; MATRIX ATTACHMENT REGION BINDING PROTEIN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; SATB2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

AGED; ARTICLE; CECUM; CECUM TUMOR; COLON; COLON TUMOR; DOWN REGULATION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MEDULLARY CARCINOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; SENSITIVITY AND SPECIFICITY; TISSUE MICROARRAY; TUMOR VOLUME; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOSINE TRIPHOSPHATASES; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CADHERINS; CARCINOMA, MEDULLARY; CECAL NEOPLASMS; CECUM; COLON; COLONIC NEOPLASMS; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX ATTACHMENT REGION BINDING PROTEINS; MIDDLE AGED; NEOPLASM PROTEINS; NUCLEAR PROTEINS; SENSITIVITY AND SPECIFICITY; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR BURDEN;

EID: 84907274851     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: 10.5858/arpa.2013-0452-OA     Document Type: Article

References (32)

1. Rüschoff J, Dietmaier W, Lüttges J, et al. Poorly differentiated colonic adenocarcinoma, medullary type: clinical, phenotypic, and molecular characteristics. Am J Pathol. 1997;150(5): 1815-1825.
2. Reyes CV, Siddiqui MT. Anaplastic carcinoma of the colon: clinicopathologic study of eight cases of a poorly recognized lesion. Ann Diagn Pathol. 1997;1(1): 19-25.
3. Jessurun J, Romero-Guadarrama M, Manivel JC. Medullary adenocarcinoma of the colon: clinicopathologic study of 11 cases. Hum Pathol. 1999;30(7): 843-848.
4. Kon S, Kasai K, Tsuzuki N, et al. Lymphoepithelioma-like carcinoma of rectum: possible relation with EBV. Pathol Res Pract. 2001;197(8): 577-582.
5. Arai T, Esaki Y, Sawabe M, Honma N, Nakamura K, Takubo K. Hypermethylation of the hMLH1 promoter with absent hMLH1 expression in medullary-type poorly differentiated colorectal adenocarcinoma in the elderly. Mod Pathol. 2004;17(2): 172-179.
6. Thirunavukarasu P, Sathaiah M, Singla S, et al. Medullary carcinoma of the large intestine: a population based analysis. Int J Oncol. 2010;37(4): 901-907.
7. Bosman FT, Carneiro F, Hruban RH, Theise ND, eds. WHO Classification of Tumours of the Digestive System. 4th ed. Lyon, France: IARC Press; 2010: 138.
8. Alexander J, Watanabe T, Wu TT, Rashid A, Li S, Hamilton SR. Histopathological identification of colon cancer with microsatellite instability. Am J Pathol. 2001;158(2): 527-535.
9. Hinoi T, Tani M, Lucas PC, et al. Loss of CDX2 expression and microsatellite instability are prominent features of large cell minimally differentiated carcinomas of the colon. Am J Pathol. 2001;159(6): 2239-2248.
10. Barbareschi M, Murer B, Colby TV, et al. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Am J Surg Pathol. 2003;27(2): 141-149.
11. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003; 27(3): 303-310.
12. Moskaluk CA, Zhang H, Powell SM, Cerilli LA, Hampton GM, Frierson HF Jr. Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays. Mod Pathol. 2003;16(9): 913-919.
13. Raspollini MR, Baroni G, Taddei A, Taddei GL. Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix: an investigation using Cdx-2 and a limited immunohistochemical panel. Arch Pathol Lab Med. 2003;127(12): 1586-1590.
14. Kaimaktchiev V, Terracciano L, Tornillo L, et al. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Mod Pathol. 2004;17(11): 1392-1399.
15. Houghton O, Connolly LE, McCluggage WG. Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2. Histopathology. 2008;53(2): 156-165.
16. Winn B, Tavares R, Fanion J, et al. Differentiating the undifferentiated: immunohistochemical profile of medullary carcinoma of the colon with an emphasis on intestinal differentiation. Hum Pathol. 2009;40(3): 398-404.
17. McGregor DK, Wu TT, Rashid A, Luthra R, Hamilton SR. Reduced expression of cytokeratin 20 in colorectal carcinomas with high levels of microsatellite instability. Am J Surg Pathol. 2004;28(6): 712-718.
18. SB Zhu, C Schuerch, Lin F. Absent or low expression of CK20 and CDX2 associated with microsatellite instability in poorly differentiated colorectal carcinomas (PDCC). Mod Pathol. 2005;18(1S): 124A. USACP abstract 567
19. Lin F, Liu H. Unknown primary/undifferentiated neoplasms in surgical and cytologic specimens. In: Lin F, Prichard JW, eds. Handbook of Practical Immunohistochemistry: Frequently Asked Questions. New York, NY: Springer; 2011: 55-84.
20. Wick MR, Vitsky JL, Ritter JH, Swanson PE, Mills SE. Sporadic medullary carcinoma of the colon: a clinicopathologic comparison with nonhereditary poorly differentiated enteric-type adenocarcinoma and neuroendocrine colorectal carcinoma. Am J Clin Pathol. 2005;123(1): 56-65.
21. Chu P, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol. 2000;13(9): 962-972.
22. Angres B, Kim L, Jung R, Gessner R, Tauber R. LI-cadherin gene expression during mouse intestinal development. Dev Dyn. 2001;221(2): 182-193.
23. Berndorff D, Gessner R, Kreft B, et al. Liver-intestine cadherin: molecular cloning and characterization of a novel Ca(2+)-dependent cell adhesion molecule expressed in liver and intestine. J Cell Biol. 1994;125(6): 1353-1369.
24. Su MC, Yuan RH, Lin CY, Jeng YM. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system. Mod Pathol. 2008;21(11): 1379-1386.
25. Panarelli NC, Yantiss RK, Yeh MM, Liu Y, Chen YT. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Am J Clin Pathol. 2012;138(2): 211-222.
26. Wang S, Zhou J, Wang XY, et al. Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer. J Pathol. 2009;219(1): 114-122.
27. Magnusson K, de Wit M, Brennan DJ, et al. SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas. Am J Surg Pathol. 2011;35(7): 937-948.
28. Timek DT, Shi J, Liu H, Lin F. Arginase-1, HepPar-1, and Glypican-3 are the most effective panel of markers in distinguishing hepatocellular carcinoma from metastatic tumor on fine-needle aspiration specimens. Am J Clin Pathol. 2012; 138(2): 203-210.
29. Lin F, Shi J, Liu H, et al. Diagnostic utility of S100P and von Hippel-Lindau gene product (pVHL) in pancreatic adenocarcinoma-with implication of their roles in early tumorigenesis. Am J Surg Pathol. 2008;32(1): 78-91.
30. Conner JR, Hornick JL. SATB2 is a novel marker of osteoblastic differentiation in bone and soft tissue tumours. Histopathology. 2013;63(1): 36-49.
31. Li Z, Zhou K, Mei K, Kang Q, Cao D. SATB2 is a highly sensitive marker for hindgut well-differentiated neuroendocrine tumors. Mod Pathol. 2013;26(S2): 164A. USCAP abstract 682.
32. Chen ZM, Wang HL. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine. Am J Surg Pathol. 2004;28(10): 1352-1359.